The FDA declined to consider elamipretide for full approval in 2021 and rejected the company's application in May of 2025 ...

DSAP is a premalignant, progressive disease characterized by numerous expanding lesions which significantly impact quality-of ...

Immuron receives U.S. Food and Drug administration (FDA) approval for IMM-529 Investigational New Drug (IND) application and clinical study may proceed FDA assigned an IND number (032095) for the ...

The Federal High Court in Lagos has approved the request of the National Drug Law Enforcement Agency (NDLEA) for the interim ...

First and Last Bakery, LLC, which is based in Hartford, Connecticut, issued the recall for three varieties of its tomato ...

ADCs remain à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to advance its pipeline in the ...

Lungpacer Medical has began subject enrolment in Phase II STimulation to Activate RespIration (STARI) trial, assessing the ...

GLOBAL RELEASE - NOT INTENDED FOR UK MEDIA LEO Pharma, a global leader in medical dermatology, today announced that the National Institute for Health and Care Excellence (NICE) has issued Technology ...

Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President ...

SCOTUS delays marijuana & guns case; OK legalization effort fails; MA cannabis bill advances; Alcohol groups push Congress on ...

The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive ...